Analysts’ Opinions Are Mixed on These Healthcare Stocks: AMN Healthcare Services (AMN), Vanda (VNDA) and BioMarin Pharmaceutical (BMRN)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AMN Healthcare Services (AMN – Research Report), Vanda (VNDA – Research Report) and BioMarin Pharmaceutical (BMRN – Research Report).
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
AMN Healthcare Services (AMN)
William Blair analyst Trevor Romeo maintained a Hold rating on AMN Healthcare Services today. The company’s shares closed last Friday at $16.25.
According to TipRanks.com, Romeo is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for AMN Healthcare Services with a $23.50 average price target.
See today’s best-performing stocks on TipRanks >>
Vanda (VNDA)
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Vanda, with a price target of $22.00. The company’s shares closed last Friday at $6.09.
According to TipRanks.com, Selvaraju is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Vanda with a $13.63 average price target, implying a 124.2% upside from current levels. In a report issued on February 12, Cantor Fitzgerald also maintained a Buy rating on the stock with a $11.00 price target.
BioMarin Pharmaceutical (BMRN)
H.C. Wainwright analyst Mitchell Kapoor reiterated a Hold rating on BioMarin Pharmaceutical today and set a price target of $60.00. The company’s shares closed last Friday at $59.87.
According to TipRanks.com, Kapoor is a 4-star analyst with an average return of
BioMarin Pharmaceutical has an analyst consensus of Moderate Buy, with a price target consensus of $88.29.
